These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36149769)

  • 1. Loss of lung microvascular endothelial Piezo2 expression impairs NO synthesis, induces EndMT, and is associated with pulmonary hypertension.
    Tian S; Cai Z; Sen P; van Uden D; van de Kamp E; Thuillet R; Tu L; Guignabert C; Boomars K; Van der Heiden K; Brandt MM; Merkus D
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H958-H974. PubMed ID: 36149769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertension.
    Philip N; Yun X; Pi H; Murray S; Hill Z; Fonticella J; Perez P; Zhang C; Pathmasiri W; Sumner S; Servinsky L; Jiang H; Huetsch JC; Oldham WM; Visovatti S; Leary PJ; Gharib SA; Brittain E; Simpson CE; Le A; Shimoda LA; Suresh K
    Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L252-L265. PubMed ID: 38226418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species induced Ca
    Suresh K; Servinsky L; Jiang H; Bigham Z; Yun X; Kliment C; Huetsch J; Damarla M; Shimoda LA
    Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L893-L907. PubMed ID: 29388466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of mitochondrial fragmentation in microvascular endothelial cells isolated from the SU5416/hypoxia model of pulmonary arterial hypertension.
    Suresh K; Servinsky L; Jiang H; Bigham Z; Zaldumbide J; Huetsch JC; Kliment C; Acoba MG; Kirsch BJ; Claypool SM; Le A; Damarla M; Shimoda LA
    Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L639-L652. PubMed ID: 31461316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.
    Zhang Q; Yaoita N; Tabuchi A; Liu S; Chen SH; Li Q; Hegemann N; Li C; Rodor J; Timm S; Laban H; Finkel T; Stevens T; Alvarez DF; Erfinanda L; de Perrot M; Kucherenko MM; Knosalla C; Ochs M; Dimmeler S; Korff T; Verma S; Baker AH; Kuebler WM
    Circulation; 2024 Aug; 150(6):466-487. PubMed ID: 38873770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition.
    Yu M; Peng L; Liu P; Yang M; Zhou H; Ding Y; Wang J; Huang W; Tan Q; Wang Y; Xie W; Kong H; Wang H
    Drug Des Devel Ther; 2020; 14():1191-1202. PubMed ID: 32256050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MnTBAP Reverses Pulmonary Vascular Remodeling and Improves Cardiac Function in Experimentally Induced Pulmonary Arterial Hypertension.
    Gomez-Puerto MC; Sun XQ; Schalij I; Orriols M; Pan X; Szulcek R; Goumans MJ; Bogaard HJ; Zhou Q; Ten Dijke P
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired Interleukin-15 Signaling via
    Hilton LR; Rätsep MT; VandenBroek MM; Jafri S; Laverty KJ; Mitchell M; Theilmann AL; Smart JA; Hawke LG; Moore SD; Renaud SJ; Soares MJ; Morrell NW; Ormiston ML
    Hypertension; 2022 Nov; 79(11):2493-2504. PubMed ID: 36043416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial-to-mesenchymal transition in pulmonary hypertension.
    Ranchoux B; Antigny F; Rucker-Martin C; Hautefort A; Péchoux C; Bogaard HJ; Dorfmüller P; Remy S; Lecerf F; Planté S; Chat S; Fadel E; Houssaini A; Anegon I; Adnot S; Simonneau G; Humbert M; Cohen-Kaminsky S; Perros F
    Circulation; 2015 Mar; 131(11):1006-18. PubMed ID: 25593290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage.
    Szulcek R; Happé CM; Rol N; Fontijn RD; Dickhoff C; Hartemink KJ; Grünberg K; Tu L; Timens W; Nossent GD; Paul MA; Leyen TA; Horrevoets AJ; de Man FS; Guignabert C; Yu PB; Vonk-Noordegraaf A; van Nieuw Amerongen GP; Bogaard HJ
    Am J Respir Crit Care Med; 2016 Jun; 193(12):1410-20. PubMed ID: 26760925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial upregulation of mechanosensitive channel Piezo1 in pulmonary hypertension.
    Wang Z; Chen J; Babicheva A; Jain PP; Rodriguez M; Ayon RJ; Ravellette KS; Wu L; Balistrieri F; Tang H; Wu X; Zhao T; Black SM; Desai AA; Garcia JGN; Sun X; Shyy JY; Valdez-Jasso D; Thistlethwaite PA; Makino A; Wang J; Yuan JX
    Am J Physiol Cell Physiol; 2021 Dec; 321(6):C1010-C1027. PubMed ID: 34669509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-181b-5p inhibits endothelial-mesenchymal transition in monocrotaline-induced pulmonary arterial hypertension by targeting endocan and TGFBR1.
    Zhao H; Wang Y; Zhang X; Guo Y; Wang X
    Toxicol Appl Pharmacol; 2020 Jan; 386():114827. PubMed ID: 31734320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension.
    Gorelova A; Berman M; Al Ghouleh I
    Antioxid Redox Signal; 2021 Apr; 34(12):891-914. PubMed ID: 32746619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition.
    Huang J; Lu W; Ouyang H; Chen Y; Zhang C; Luo X; Li M; Shu J; Zheng Q; Chen H; Chen J; Tang H; Sun D; Yuan JX; Yang K; Wang J
    Am J Respir Cell Mol Biol; 2020 Jan; 62(1):49-60. PubMed ID: 31211918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Aquaporin 1 Mediates Increased Migration and Proliferation in Pulmonary Vascular Cells From the Rat SU5416/Hypoxia Model of Pulmonary Hypertension.
    Yun X; Philip NM; Jiang H; Smith Z; Huetsch JC; Damarla M; Suresh K; Shimoda LA
    Front Physiol; 2021; 12():763444. PubMed ID: 34975522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
    Born E; Lipskaia L; Breau M; Houssaini A; Beaulieu D; Marcos E; Pierre R; Do Cruzeiro M; Lefevre M; Derumeaux G; Bulavin DV; Delcroix M; Quarck R; Reen V; Gil J; Bernard D; Flaman JM; Adnot S; Abid S
    Circulation; 2023 Feb; 147(8):650-666. PubMed ID: 36515093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension.
    Shatat MA; Tian H; Zhang R; Tandon G; Hale A; Fritz JS; Zhou G; Martínez-González J; Rodríguez C; Champion HC; Jain MK; Hamik A
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):647-53. PubMed ID: 24156273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
    Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP
    Life Sci; 2019 Jun; 227():64-73. PubMed ID: 31004656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling.
    Cai D; Chen SY
    Redox Biol; 2022 Dec; 58():102524. PubMed ID: 36334380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.